Corticosteroid effects on proximal femur bone loss

Area of Science:

• Endocrinology
• Orthopedics
• Bone Metabolism

Background:

• Prolonged high-dose corticosteroid therapy is a known risk factor for osteoporotic fractures.
• Previous studies documented corticosteroid-induced bone density loss at the radius and spine.
• Limited research has examined corticosteroid effects on hip bone density, a critical fracture site.

Purpose of the Study:

• To investigate the impact of corticosteroid treatment on bone mineral density (BMD) at the hip.
• To assess BMD changes in the proximal femur and lumbar spine in patients on corticosteroid therapy.

Main Methods:

• Dual-photon absorptiometry was used to measure BMD at three proximal femur sites and the lumbar spine in 32 patients.
• Patients received corticosteroids (mean 12.7 mg prednisone daily) for up to 23 years.
• BMD values were compared to age-matched normal subjects; serial BMD measurements were also performed in 29 patients.

Main Results:

• Significant reductions in BMD were observed at the femoral neck, Ward's triangle, and trochanteric region (p < 0.001).
• Lumbar spine BMD was also significantly decreased (p < 0.001).
• Serial measurements showed annual BMD decline in both the lumbar spine and femoral neck, particularly in the acute treatment group.

Conclusions:

• Corticosteroid therapy leads to significant bone loss at the hip, a major site for osteoporotic fractures.
• The findings underscore the detrimental effect of corticosteroids on hip bone density.
• Further research and preventative strategies are warranted for patients on long-term corticosteroid treatment.